PACB — Pacific Biosciences of California Share News
0.000.00%
Last trade - 00:00- $609.23m
- $1.02bn
- $160.01m
Brief: Pacific Biosciences Of California, Inc. Announces Pricing Of Upsized Public Offering Of Common Stock
Brief: Pacific Biosciences Of California Inc Announces Proposed Public Offering Of Common Stock
Brief: Pacific Biosciences Announces Record Orders In Q4 2022
Focus: Cancer researchers question antitrust arguments against Illumina-Grail deal
Focus: Cancer researchers question antitrust arguments against Illumina-Grail deal
Brief: Pacbio And Boston Children's Hospital Collaborate To Investigate Novel Variants
U.S. RESEARCH ROUNDUP-Abbvie, Eli Lilly, Vroom
U.S. RESEARCH ROUNDUP-Caterpillar, Endava, Harpoon Therapeutics
Brief: Pacific Biosciences Of California Inc Reports Q3 Adjusted Loss Per Share Of $0.32
Pacific Biosciences of California Inc reports results for the quarter ended in September - Earnings Summary
Pacific Biosciences of California Inc expected to post a loss of 33 cents a share - Earnings Preview
Brief: PacBio Announces That Euan Ashley, Joseph Puglisi, And Jay Shendure Join Newly Created Scientific Advisory Board
Pacific Biosciences of California Inc expected to post a loss of 33 cents a share - Earnings Preview
PacBio to launch new gene-sequencing systems
Brief: Pacbio Announces Onso, The Highly Accurate Short-Read Sequencing Platform
Brief: Pacific Biosciences Withdraws All Prior Financial Guidance
Brief: Pacbio Launches Single-Cell Transcriptome Solution
Brief: Pacbio And Twist Bioscience Deliver Initial Portfolio Of Target Enrichment Panels For Hifi Sequencing
Brief: Pacbio Collaborates To Establish Long-Read Variant Frequency Consortium